Cargando…

Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis

OBJECTIVE: To identify whether musculoskeletal ultrasound (MSUS) abnormalities are associated with specific phases of rheumatoid arthritis (RA) development in individuals at risk of RA. METHODS: This is a prospective cohort study of individuals at risk of developing RA, namely first-degree relatives...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brulhart, Laure, Alpízar-Rodríguez, Deshiré, Nissen, Michael S, Zufferey, Pascal, Ciubotariu, Ileana, Fleury, Gregory, Lazarou, Ilias, Gabay, Cem, Finckh, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Education
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744083/ https://www.ncbi.nlm.nih.gov/pubmed/31565240 http://dx.doi.org/10.1136/rmdopen-2019-000922

Ejemplares similares

The Role of Nutritional Factors and Intestinal Microbiota in Rheumatoid Arthritis Development
por: Alpízar-Rodríguez, Deshiré, et al.
Publicado: (2020)

Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
por: Riek, Myriam, et al.
Publicado: (2023)

A systematic review of infliximab in the treatment of early rheumatoid arthritis
por: Du Pan, Sophie Martin, et al.
Publicado: (2007)

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
por: Jarlborg, Matthias, et al.
Publicado: (2020)

Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years
por: Möller, Burkhard, et al.
Publicado: (2020)

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland
por: Finckh, A, et al.
Publicado: (2020)

Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort
por: Micheroli, Raphael, et al.
Publicado: (2022)

Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients
por: Singwe-Ngandeu, Madeleine, et al.
Publicado: (2010)

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists
por: Finckh, Axel, et al.
Publicado: (2012)

Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study
por: Wells, Philippa M, et al.
Publicado: (2020)

A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance
por: Martinez-Prat, Laura, et al.
Publicado: (2018)

Editorial: The interplay between the oral Microbiota and rheumatoid arthritis
por: Manoil, Daniel, et al.
Publicado: (2022)

Teaching students to R(3)eason, not merely to solve problem sets: The role of philosophy and visual data communication in accessible data science education
por: Ciubotariu, Ilinca I., et al.
Publicado: (2023)

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
por: Finckh, A, et al.
Publicado: (2010)

Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort study
por: Lamacchia, Celine, et al.
Publicado: (2023)

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review
por: Rubbert-Roth, Andrea, et al.
Publicado: (2009)

Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype
por: Snelling, Sarah J. B., et al.
Publicado: (2017)

Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland
por: Vallejo-Yagüe, Enriqueta, et al.
Publicado: (2021)

Periodontitis in First Degree-Relatives of Individuals With Rheumatoid Arthritis: A Short Narrative Review
por: Zekeridou, Alkisti, et al.
Publicado: (2022)

Application of Ultrasound in Assessment of Biologics Efficacy in Patients with Rheumatoid Arthritis
por: Chen, Yen-Ju, et al.
Publicado: (2022)

A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience
por: Taylor, Peter C., et al.
Publicado: (2023)

Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency
por: Martin, Praxedis, et al.
Publicado: (2013)

Ultrasound Scoring Systems for Evaluation of Synovitis and Tenosynovitis in Patients with Rheumatoid Arthritis
por: Lin, Ching-Tsai, et al.
Publicado: (2022)

Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease
por: Viatte, Sebastien, et al.
Publicado: (2012)

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
por: Gerlag, Danielle M, et al.
Publicado: (2012)

Autoimmune correlation of rheumatoid arthritis and periodontitis
por: Arunachalam, Lalitha Tanjore
Publicado: (2014)

Preferred Mode of Therapy Among Patients in Rheumatoid Arthritis Saudi Database: A Cross-Sectional Study
por: Bukhari, Rahaf I, et al.
Publicado: (2023)

Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
por: Burkard, Theresa, et al.
Publicado: (2021)

Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals
por: Harrison, Mark, et al.
Publicado: (2019)

Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases
por: Lamacchia, Celine, et al.
Publicado: (2023)

Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab
por: Melong Pianta Taleng, Cathy Mireille, et al.
Publicado: (2021)

Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study
por: Möller, Burkhard, et al.
Publicado: (2014)

Mesenchymal stem cells, autoimmunity and rheumatoid arthritis
por: El-Jawhari, J.J., et al.
Publicado: (2014)

The lung microbiota in early rheumatoid arthritis and autoimmunity
por: Scher, Jose U., et al.
Publicado: (2016)

Vitamin D, Autoimmune Disease and Rheumatoid Arthritis
por: Harrison, Stephanie R., et al.
Publicado: (2019)

Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network
por: Kalweit, Maria, et al.
Publicado: (2021)

Brief report: Assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis
por: Gilbert, Benoît Thomas P., et al.
Publicado: (2023)

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
por: Gabay, Cem, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uep3632660anm0u7lm0i2mm4gs